A research intervention in Uganda to test an intervention called Volunteer Support, designed to improve care for people living in the community with severe mental illness

Testing the effectiveness, acceptability and feasibility of Volunteer Support in severe mental illness in Uganda: a non-randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86689958

Enrollment

Registered

2019-03-04

Start date

2018-12-01

Completion date

Unknown

Last updated

2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with severe mental illness (including psychosis) Mental and Behavioural Disorders

Interventions

30 patients will be recruited to the Volunteer Support intervention and 30 patients will be recruited to a control condition, against which patient outcomes in Volunteer Support will be compared.

ii) engaging in productive, e.g. income-generating, activities

iii) providing practical support for accessing and utilising available professional services and care

and iv) referrals to such services if and when appropriate. It will be up to each group of patients and volunteers to decide which of these tasks to focus on. Patients in the control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of severe mental illness (ICD-10 F20-29, F31, F32) 2. Aged 18-65 years old and over 3. Capacity to provide informed consent assessed by UBACC score of =14 4. Able to communicate in Luganda or English 5. Scores 5 or below on the MANSA scale

Exclusion criteria

Exclusion criteria: 1. Primary diagnosis of substance-use disorder, organic psychosis and/or a neurocognitive disorder 2. Currently an inpatient at the time of recruitment 3. Participating in another study conducted by this or another group

Design outcomes

Primary

Measure	Time frame
Quality of life, measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline, 6 and 12 months	—

Secondary

Measure	Time frame
1. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months 2. Objective social situation, measured using the Objective Social Outcomes Index (SIX) at baseline, 6 and 12 months 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months 4. Stigma, measured using the Self-Esteem Rating Scale at baseline, 6 months and 12 months 5. Adherence to medication, using the Medication Adherence Rating Scale (MARS) at baseline, 6 and 12 months	—

Measure

Time frame

1. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months 2. Objective social situation, measured using the Objective Social Outcomes Index (SIX) at baseline, 6 and 12 months 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months 4. Stigma, measured using the Self-Esteem Rating Scale at baseline, 6 months and 12 months 5. Adherence to medication, using the Medication Adherence Rating Scale (MARS) at baseline, 6 and 12 months

—

Countries

Uganda

Contacts

Public ContactFrancois van Loggerenberg

f.vanloggerenberg@qmul.ac.uk+44 (0)207 540 4380 Ext: 2339

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026